Xavier Matias-Guiu Guia
Degree: PhD
973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat
ResearcherID: http://www.researcherid.com/rid/C-3039-2009
Groups
Publications
-
Bosse, T; Lax, S; Abu-Rustum, N; Matias-Guiu, X
The Role of Predictive Biomarkers in Endocervical Adenocarcinoma: Recommendations From the International Society of Gynecological Pathologists
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 40 102-110. .
-
Jan van Weelden W; Reijnen C; Küsters-Vandevelde HVN; Bulten J; Bult P; Leung S; Visser NCM; Santacana M; Bronsert P; Hirschfeld M; Colas E; Gil-Moreno A; Reques A; Mancebo G; Huvila J; Koskas M; Weinberger V; Bednarikova M; Hausnerova J; Snijders MPLM; Matias-Guiu X; Amant F; Krakstad C; van de Vijver K; McAlpine J; Pijnenborg J; ENITEC-consortium
The cut-off for estrogen and progesterone receptor in endometrial cancer revisited: an ENITEC collaboration study.
HUMAN PATHOLOGY 109 80-91. .
-
Concin N; Matias-Guiu X; Vergote I; Cibula D; Mirza MR; Marnitz S; Ledermann J; Bosse T; Chargari C; Fagotti A; Fotopoulou C; Martin AG; Lax S; Lorusso D; Marth C; Morice P; Nout RA; O'Donnell D; Querleu D; Raspollini MR; Sehouli J; Sturdza A; Taylor A; Westermann A; Wimberger P; Colombo N; Planchamp F; Creutzberg CL
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.
RADIOTHERAPY AND ONCOLOGY 154 327-353. .
-
Frias-Gomez J; Peremiquel-Trillas P; Alemany L; Ameijide A; Marcos-Gragera R; Ponce J; Brunet J; Matias-Guiu X; Galceran J; Izquierdo Á; Borràs JM; Costas L; Clèries R
Predicting the rising incidence and mortality of endometrial cancers among women aged 65-74 years in Catalonia.
MATURITAS 144 11-15. .
-
Concin N; Creutzberg CL; Vergote I; Cibula D; Mirza MR; Marnitz S; Ledermann JA; Bosse T; Chargari C; Fagotti A; Fotopoulou C; González-Martín A; Lax SF; Lorusso D; Marth C; Morice P; Nout RA; O'Donnell DE; Querleu D; Raspollini MR; Sehouli J; Sturdza AE; Taylor A; Westermann AM; Wimberger P; Colombo N; Planchamp F; Matias-Guiu X
ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma.
VIRCHOWS ARCHIV 478 153-190. .
-
Concin N; Matias-Guiu X; Vergote I; Cibula D; Mirza MR; Marnitz S; Ledermann J; Bosse T; Chargari C; Fagotti A; Fotopoulou C; Gonzalez Martin A; Lax S; Lorusso D; Marth C; Morice P; Nout RA; O'Donnell D; Querleu D; Raspollini MR; Sehouli J; Sturdza A; Taylor A; Westermann A; Wimberger P; Colombo N; Planchamp F; Creutzberg CL
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 31 12-39. .
-
MATIAS-GUIU GUIA, XAVIER
Endometrial Cancer Histopathology Reporting Guide
Endometrial Cancer Histopathology Reporting Guide -. .
-
Romero I; Rubio MJ; Medina M; Matias-Guiu X; Santacana M; Schoenenberger JA; Guerra EM; Cortés A; Minig L; Coronado P; Cueva JF; Gómez L; Malfettone A; Sampayo M; Llombart-Cussac A; Poveda A
An olaparib window-of-opportunity trial in patients with early-stage endometrial carcinoma: POLEN study.
GYNECOLOGIC ONCOLOGY 159 721-731. .
-
Miller RE; Leary A; Scott CL; Serra V; Lord CJ; Bowtell D; Chang DK; Garsed DW; Jonkers J; Ledermann JA; Nik-Zainal S; Ray-Coquard I; Shah SP; Matias-Guiu X; Swisher EM; Yates LR
ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer.
ANNALS OF ONCOLOGY 31 1606-1622. .
-
Mellid S; Coloma J; Calsina B; Monteagudo M; Roldán-Romero JM; Santos M; Leandro-García LJ; Lanillos J; Martínez-Montes ÁM; Rodríguez-Antona C; Montero-Conde C; Martínez-López J; Ayala R; Matias-Guiu X; Robledo M; Cascón A
Novel DNMT3A Germline Variant in a Patient with Multiple Paragangliomas and Papillary Thyroid Carcinoma.
Cancers 12 1-12. .
-
Rodriguez-Hernandez I; Maiques O; Kohlhammer L; Cantelli G; Perdrix-Rosell A; Monger J; Fanshawe B; Bridgeman VL; Karagiannis SN; Penin RM; Marcolval J; Marti RM; Matias-Guiu X; Fruhwirth GO; Orgaz JL; Malanchi I; Sanz-Moreno V
WNT11-FZD7-DAAM1 signalling supports tumour initiating abilities and melanoma amoeboid invasion.
Nature Communications 11 5315-5315. .
-
Cuatrecasas M; Gorostiaga I; Riera C; Saperas E; Llort G; Costa I; Matias-Guiu X; Carrato C; Navarro M; Pineda M; Dueñas N; Brunet J; Marco V; Trias I; Busteros JI; Mateu G; Balaguer F; Fernández-Figueras MT; Esteller M; Musulén E
Complete Loss of EPCAM Immunoexpression Identifies EPCAM Deletion Carriers in MSH2-Negative Colorectal Neoplasia.
Cancers 12 1-20. .
Projects
- Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
- EPH Receptor Signaling in Endometrial Cancer
- Ajuts per a la contractació de personal investigador novell (FI)
- Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
- "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
- EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
- Incorporación de nuevas areas temáticas y nuevos grupos al consorcio CIBER
- Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
- CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
- DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
- Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
- VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU